Arvinas(ARVN) Stock Price Today | Quotes & News

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer’s & Parkinson’s Diseases
ReutersMar 27 07:00 ET
Arvinas Announces Oral Presentation at 2025 International Conference on Alzheimer's & Parkinson's Diseases
ArvinasMar 27 00:00 ET
Top 3 Health Care Stocks That Are Set To Fly This Month
BenzingaMar 26 07:06 ET
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Arcutis Biotherapeutics (ARQT)
TipRanksMar 24 20:30 ET · Ratings
Express News | Arvinas Inc : Leerink Partners Cuts Target Price to $12 From $49
ReutersMar 21 06:06 ET
New Analyst Forecast: $ARVN Given $12.0 Price Target
Quiver QuantitativeMar 18 14:21 ET

Comments

MMile Contractor

Mar 11 19:42

$Arvinas (ARVN.US)$ What happen bruh

2

Teddy123

Mar 11 18:48

Arvinas and Pfizer Announce Positive Topline Results from Phase 3 VERITAC-2 Clinical Trial

$Arvinas (ARVN.US)$
First-Ever PROTAC Cancer Drug Hits Major Trial Milestone: What This Means

2

Moomoo AI

Feb 27, 2024 03:36

Arvinas' high P/S ratio could be worrisome as revenue forecasts are not promising. The anticipated future revenues may not sustain the current positive sentiment. Without significant improvements, these prices may not be deemed reasonable.

Revenues Not Telling The Story For Arvinas, Inc. (NASDAQ:ARVN) After Shares Rise 28%

1

Moomoo AI

Feb 21, 2024 05:08

Sean Cassidy expressed confidence in the company's future and the promising clinical development and commercial opportunity for the PROTAC(R) protein degrader pipeline. The company's leadership acknowledged Cassidy's pivotal role in creating Arvinas' strong financial profile.

Press Release: Arvinas Announces Chief Financial Officer Transition

2

JP88

Dec 9, 2023 07:35

$Arvinas (ARVN.US)$ I hope everyone bought that sub 14 dip! This thing has been a beast.

1

ARVN Arvinas

Trade Overview

Capital Trend

News

Comments

Market Insights